Latest filing published 27 Jun 2024 for Oncopeptides AB (publ.).
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Cecilia Daun Wennborg: trading record in brief
Filings by Cecilia Daun Wennborg span 2 companies, the busiest being Oncopeptides AB and Oncopeptides AB (publ.). The record holds 5 filings, for trades running from 22 February 2017 to 27 June 2024.
No open-market sale appears; the market trades are 3 purchases worth €67k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.
A typical purchase (the median) is worth €29k.
The newest entry dates from 27 June 2024: a share grant, in Oncopeptides AB (publ.). The last insider purchase was made public on 16 August 2018, 3,007 days ago. Most trades are made public on the day they happen. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cecilia Daun Wennborg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,292 shares0AktieISIN SE0009414576FI:csv-e46da671bb413ad5309e
- 5,800 shares0AktieISIN SE0009414576FI:csv-2d34b422805f17b48ca0
- 2,000 shares@ SEK 149.5199ISIN SE0009414576FI:csv-f4e6e165b093e2275737Canonical exit: 14 Nov 2018 (T+90)
- 2,000 shares@ SEK 149.3941ISIN SE0009414576FI:csv-4bf2ce68a4f99456e7cfCanonical exit: 14 Nov 2018 (T+90)
- 2,000 shares@ SEK 46.00ISIN SE0009414576FI:csv-8393c285a470a981d6f0Canonical exit: 23 May 2017 (T+90)
5 of 5 declarations